Mathys History
We are Mathys – and our story dates back to 1946!
Discover how a small family business became an international orthopaedic company and follow the traces of time:
1946
Foundation of the company
At just 25, Robert Mathys establishes the company Rob. Mathys & Co., with the commercial registry entry dated 1 June 1946. Robert Mathys specialises in processing stainless steel, and buys three second-hand automatic lathes and begins production in mid-June. This is the corner-stone for today’s Mathys Ltd Bettlach.
1958
Maurice E. Müller and Robert Mathys
Maurice E. Müller meets Robert Mathys. This is the impetus for the move into medical technology: Mathys begins developing and producing implants and instruments for knee surgery and orthopaedics. He attends operations at the hospital in Grenchen to gain insights into the subject.
1961
First implantation of a hip joint in Europe
On 9 February 1961, Maurice E. Müller implants the first hip prosthesis developed by Robert Mathys into a patient. It is the first implant of an artificial hip joint on the European continent.
1967
Development and production for Protek
Mathys begins production of artificial hip joints for the company Protek in Bern, owned by Maurice E. Müller. This is the inception of the second mainstay of the company’s activities. In addition to screws and plates, it now also produces artificial joints.
1973
RM Cup
The beginning of the uncemented elastic monoblock cup. This is developed on the basis of the design of the cemented Müller cup with the aim of achieving high primary implant stability without bone cement.
1974
Doctor honoris causa
The Faculty of Medicine of the University of Bern awards Robert Mathys an honorary doctorate with the title «Doctor honoris causa» for his contributions to the field of bone medicine. In his nomination letter to the Dean of the Faculty of Medicine, surgeon Maurice E. Müller writes: «In Mr Mathys, the faculty would be awarding an honorary doctorate to a simple man who has made pioneering achievements in the field of bone surgery.»
1981
The great growth
Worldwide, Robert Mathys Co. employs over 400 staff. The product range has grown to 3,149 products. The company’s clients include 8,000 hospitals, and 95 % of production is exported. The most important markets are France and Germany.
1983
RM Classic
Mathys’ own «RM» (Robert Mathys) titanium coating is first used in the RM Classic. The titanium particles enable the osseointegration of the implant. They are individually anchored in the polyethylene and not structurally connected to each other. The elasticity of the implant is therefore not changed by the coating.
1991
Independence
The Mathys shareholders lay the strategic foundation for the establishment of a dedicated orthopaedics division. Hugo Mathys takes charge of setting up the Joint Replacement Division. This will later prove an important decision in the company’s ability to survive independently.
1996
Marketing of first products under own name
Robert Mathys Jr takes over as Chairman of the Board of Directors of «Mathys Medizinaltechnik AG». The company celebrates its 50th anniversary with a big celebration and a new brand image. Over a number of decades, Mathys produces hip joints for Müller’s company Protek until it is acquired by Sulzer Medica in 1996. Drawing on its 35 years of experience, Mathys starts marketing its joint prostheses under its own name in 1996. Five years earlier, Mathys set a deliberate course for this point with its strategic focus on joint replacement.
1998
balanSys BICONDYLAR
The proven, stable and enhanced knee system balanSys BICONDYLAR is first implanted in 1998. Ahead of ist time when introduced, it is still going strong today and has been subject to further technological development in recent years with the launch of leggera instruments and vitamys inlays.
2002
Acquisition of «Keramed Medizintechnik GmbH»
Mathys acquires the company Keramed in Germany. The company is specialised in ceramic materials, with which Mathys has been experimenting in the field of joint replacements for years. In the early 1970s, Keramed was one of the first companies worldwide to develop and sell bioceramics for endoprosthetics.
2002
RM Pressfit
Based on the proven concept of the elastic RM Classic cup, development continues with the introduction of an RM Pressfit version without pegs.
2003
Selling of the Osteosynthesis to «Synthes»
The Mathys family decides to sell the Osteosynthesis Unit and thus 90 % of the company’s volume to Synthes USA. The new Mathys Ltd Bettlach now focuses on hip, knee and shoulder prostheses. CEO Hugo Mathys leads the company, alongside Chairman of the Board of Directors Robert Mathys Jr, who will pass down that role tot Hugo Mathys a few years later.
2007
ceramys
Five years after the acquisition of Keramed, Mathys launches its first heads made of dispersion ceramic – ceramys – for use in hip arthroplasty. All Mathys ceramics are developed, produced and tested internally.
2008
The third generation
Livio Marzo becomes the first member of the third generation of the family to join the Mathys Board of Directors. Marzo is CEO of Thommen Medical Group, which specialises in artificial tooth root replacements. The Thommen Medical Group’s dental implants also originated with Mathys.
2009
RM Pressfit vitamys
The RM cup undergoes the next step in its development and from now on is offered in vitamys. vitamys is a vitamin E-enriched, highly cross-linked polyethylene with high elasticity, high resistance to wear and oxidation and good mechanical strength.
2009
Affinis Short
Mathys makes a pioneering achievement in development with the stemless shoulder prosthesis. Mathys set itself the objective of developing a solution that united the advantages of simple anatomic reconstruction without major bone loss. The result is Affinis Short.
2010
optimys
With the optimys short stem, Mathys achieved a further pioneering development. The prosthesis is developed to reconstruct the individual anatomical conditions of the patient with a bone-preserving design.
2012
Ligamys
With Ligamys, Mathys gains a foothold in the field of sports orthopaedics. Ligamys is a method for the treatment of cruciate ligament tears in which the original cruciate ligament and its functions are preserved. A further product that reflects the principle of «Preservation in motion».
2013
The «Robert Mathys Strasse»
«Güterstrasse» in Bettlach is renamed «Robert Mathys Strasse» in a ceremony attended by ten grandchildren and great-grandchildren of the company founder. In front of the house in which the entire company history began, a granite commemorative plaque is unveiled.
2015
Roger Mathys is elected to the Board of Directors
Test pilot Roger Mathys becomes the second member of the third generation to join the Board of Directors of Mathys Ltd Bettlach, succeeding his father, Robert Mathys Jr.
2017
New CEO Dr Benjamin Reinmann
After a three-year consolidation phase, Hugo Mathys hands over the operational management of Mathys Ltd Bettlach to Benjamin Reinmann. Originally a physician, Reinmann comes from the family-run business Ypsomed, where he worked for 12 years. «I know what I’m getting into», he says on taking on the role.
2020
Livio Marzo becomes Chairman of the Board of Directors
Hugo Mathys hands the chairmanship of the Board of Directors to his nephew Livio Marzo and thus the third Mathys generation. Though impacted by the coronavirus pandemic, Mathys Ltd Bettlach nevertheless posts a profit at year end.
2021
75 years Mathys
Mathys celebrates its 75th anniversary and the hundredth birthday of its founder Dr Robert Mathys. It is an extraordinary company history in many ways, one that underscores the slogan «Preservation in motion» and the values pioneering, cooperative and proven.
Furthermore, Mathys is joining forces with the American company DJO to strengthen its position in the growing market of joint replacements.
Company culture
We are convinced that our customers and employees greatly benefit from a strong, solid company culture.
To nurture and at the same time further develop this culture is therefore extremely important, which is why it focuses onour mission, vision and our five company values: They are binding worldwide and are standard for all employees.
Our values have been laid down in writing by twelve employees from various divisions. They describe our conduct and which characteristics we consider important in day-to-day business.